PROVIDER PROFILE · NPI 1851495493

Vijaya GantaMD

EndocrinologyWashington, DCI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

218

Distinct HCPCS

Medicare payment

$19K

Peer benchmark

Total Medicare services vs. 32 Endocrinology providers in DC — bottom quintile (cohort median 727).

PRESCRIBING · PART D · 2024

Total Rx claims

420

Beneficiaries

—

Total drug cost

$35K

Distinct drugs

Brand share

35.0%

Top prescribed drugs

Metformin Hcl77 claims

Levothyroxine Sodium53 claims

Atorvastatin Calcium52 claims

Insulin Glargine,hum.Rec.Anlog29 claims

Simvastatin25 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$99

Payment records

By payment type

Food and Beverage$99

REFERRAL NETWORK

Where Vijaya Ganta's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
HOWARD UNIVERSITY HOSPITAL CORP	240	894
Gail Nunlee-Bland Pediatric Medicine · Washington, DC	61	98
Wolali Odonkor Endocrinology · Washington, DC	46	62
NABHANI, HASAN	25	48
Estelle Cooke-Sampson Diagnostic Radiology · Washington, DC	21	64
Bonnie Davis Diagnostic Radiology · Washington, DC	15	20
NPI 1174551550	15	25
NPI 1205945268	12	20
Kamyar Sartip Diagnostic Radiology · Kensington, MD	11	16
NPI 1285743252	11	27

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history